Human Growth Hormone Supplements Steroid Powder Ipamorelin 2mg / vial

CAS 170851-70-4 Human Growth Steroid Powder Ipamorelin 2mg / vial

1. Quick Detail:

Unit Size :2 mg/vial
Unit Quantity :1 Vial
CAS NO. 170851-70-4
Synonyms Ipamorelin
Molecular Formula C38H49N9O5
Molecular Weight 711.85
Sequence H-Aib-His-D-2-Nal-D-Phe-Lys-NH2
Appearance White Powder
Purity 98.49%
Identity (ESI-MS) 711.85±0.5
Source Chemical Synthesis
Storage Lyophilized Ipamorelin is stable at room temperature for 90 days,however it should be stored
in a freezer below -8C for any extended period of time. After reconstituting Ipamorelin should be
refrigerated at temperatures not to exceed 36 F.
CAS 170851-70-4 Human Growth Hormone Supplements Steroid Powder Ipamorelin 2mg / vial
2. Description:

Ipamorelin is a fascinating new muscle building discovery that is getting a lot of attention in the bodybuilding world. It is a synthetic peptide that has powerful Growth Hormone releasing properties.
And these GH releasing properties are what is of interest to athletes and bodybuilders since they can make a tremendous difference in the amount of muscle you can grow and how quickly you burn fat.
Ipamorelin is a penta-peptide. (Aib-His-D-2-Nal-D- Phe-LysNH2) And, the strength it displays may very well make regular old Growth Hormone (GH) obsolete. But what athletes and bodybuilders really want to know is what is this wonder peptide capable of doing, how is it used, and how does it compare to the other GHRP peptides?

Athletes are taking Ipamorelin in a 200mcg300mcg dosage, two or three times daily, using a tiny insulin needle to inject. They usually start with the lower dose since side effects can include headaches or what feels like a head-rush. Ipamorelin can be taken at anytime but taking it about 30-45 minutes before a workout would seem ideal because of the pulse in Growth Hormone (GH) it creates allowing for maximum growth.Studies on the effects of Ipamorelin on bone growth, body weight, and GH release showed some interesting conclusions.In one experiment, various doses were administered over the course of 15 days to test the group's reactions.

There was a distinct and dosedependent effect on body weight gain however,the treatment group did not show a change in total IGFI levels. Nor did the treatment group produce serum markers of bone development. For example, the number of cells in the wide portion of the tibia (the shinbone) did not change significantly. This is a good thing because it suggests muscle growth with less potential for deformity of bone or cartilage.

Permanent link: http://www.vvchem.com/sell/cas:170851-70-4,3325457.html